Researchers have developed a novel molecular glue, CLEO4-88, capable of selectively dampening the activity of disease-causing proteins. This approach differs from traditional molecular glues by binding to a single protein and inducing a conformational change that enables it to interact with a second protein, rather than marking one for destruction. The method was successfully demonstrated in targeting a protein involved in prostate cancer and a metabolic protein, offering a new therapeutic strategy for previously undruggable targets. AI
影响 Offers a new therapeutic strategy for targeting previously undruggable proteins, potentially impacting drug development for cancers and metabolic disorders.
排序理由 The cluster describes a scientific paper detailing a new method for drug discovery and a specific molecular glue developed by researchers. [lever_c_demoted from research: ic=1 ai=0.4]
- ACAA1
- Canadian Light Source
- CLEO4-88
- Dr. Chetan Chana
- Nature Chemical Biology
- University of British Columbia
- University of Toronto
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
